A Pilot Study on the Effect and Safety of Iluvien® in Chronic Diabetic Macular Edema Patients

Summary

To provide treating physicians with experience with ILUVIEN as well as monitoring its safety (and effectiveness) in a real-life chronic diabetic macular edema (DME) patients judged insufficiently responsive to available therapies.

Timeline

Start

2014-10

Primary completion

2016-03

Completion

2016-12

Drugs

Indications